TR-1 notification of major interest in shares

The full annoucement can be read here.

EKF Diagnostics

EKF Diagnostics Holdings plc is a manufacturer and distrbutor of IVD products. It has three core divisions: Point of Care including hemoglobin and HbA1c analyzers; Central Laboratory including the manufacture of enzymes and clinical chemistry; and Molecular Diagnostics which incorporates a unique DNA enrichment technology, PointMan, and a portfolio of molecular testing services.

News & events

EKF publish new diabetes and HbA1c testing guide

EKF Diagnostics, the global in vitro diagnostics company, has published a guide to ‘Diabetes and HbA1c testing’. This new educational guide draws on EKF’s expertise in the diagnosis and monitoring of diabetes and associated conditions.

Liverpool FC use the Biosen for pre-season lactate threshold training program

Behind the scenes footage from Liverpool FC TV (LFCTV) shows the first team using the EKF Diagnostics Biosen C-Line analyzer as part of their pre-season lactate threshold testing program.

EKF POCT HbA1c testing comparable to lab-based HPLC

Point of Care EKF Quo-Test HbA1c analyzer successfully evaluated at Swansea University Diabetes Research Unit.

Distributors meeting during AACC - August 2017

EKF Diagnostics USA will be holding meetings during the course of AACC at the nearby Omni San Diego Hotel. Our meeting days will be 1st and 2nd of August.

Hemoglobin measurement methods

The role of technology in hemoglobin testing has led the way for the creation of innovative devices and techniques for the quantification of hemoglobin concentration in patients.